Overview

A Safety and Pharmacokinetics Study of ASP0456 in Healthy Subjects

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending dose of ASP0456 in non-elderly healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Linaclotide